Data gathered: May 29
AI Stock Analysis - Sanofi (SNY)
Analysis generated July 14, 2024. Powered by Chat GPT.
Sanofi is a global biopharmaceutical company headquartered in Paris, France. Known for its extensive portfolio that includes pharmaceuticals, vaccines, and consumer healthcare products, Sanofi operates in over 100 countries. With a commitment to healthcare innovation, Sanofi invests heavily in research and development to drive growth and maintain its competitive edge in the pharmaceutical industry.
Stock Alerts - Sanofi (SNY)
 |
Sanofi | May 28 News Alert: Press Release: Sanofi completes acquisition of DR-0201 |
|
Sanofi | May 22 News Alert: Press Release: Sanofi to acquire Vigil Neuroscience, Inc., |
|
Sanofi | May 13 AI Score is up by 25.7% in the last couple of days. |
|
Sanofi | April 4 Price is down by -5.1% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Sanofi
About Sanofi
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.
| Price | $52.08 |
| Target Price | Sign up |
| Volume | 1,420,000 |
| Market Cap | $128B |
| Year Range | $43.94 - $56.9 |
| Dividend Yield | 4.26% |
| PE Ratio | 18.38 |
| Analyst Rating | 67% buy |
| Industry | Drug Manufacturers |
In the news
C4X Discovery receives latest milestone payment from SanofiMay 27 - GlobeNewswire |
|
Press Release: Sanofi completes acquisition of DR-0201May 26 - GlobeNewswire |
|
Atherosclerosis Market - Global and Regional Analysis and Forecast, 2025-2035 Featuring AstraZeneca, Novartis, Merck, Daiichi Sankyo, GSK, Sanofi, Pfizer, BayerMay 23 - GlobeNewswire |
|
Non-Cystic Fibrosis Bronchiectasis Market Research 2025-2035, Competitive Analysis of AstraZeneca, Sanofi, Insmed, Boehringer Ingelheim, Zambon, Chiesi, Haisco, RegeneronMay 23 - GlobeNewswire |
|
 |
Sanofi (NASDAQ:SNY) Shares Sold by Lazard Asset Management LLCMay 23 - ETF Daily News |
 |
US Approves GSK’s Lung Disease Drug, Fueling Rivalry With SanofiMay 22 - Biztoc.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 10.6B | 2.89B | 7.72B | 1.87B | 0 | 0.000 |
| Q4 '24 | 7.63B | 2.27B | 5.36B | 499M | 563M | 0.682 |
| Q3 '24 | 14.2B | 4.09B | 10.1B | 2.82B | 4.25B | 1.570 |
| Q2 '24 | 11.4B | 3.39B | 7.99B | 1.11B | 2.51B | 0.930 |
| Q1 '24 | 11.1B | 3.44B | 7.68B | 1.13B | 2.86B | 0.970 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$153.12 0.5% | 49 |
 |
Eli Lilly and CompanyLLY |
$720 0.1% | 69 |
 |
PfizerPFE |
$23.31 0.6% | 44 |
 |
AstrazenecaAZN |
$70.66 0.4% | 51 |
 |
AbbVieABBV |
$185.31 1.2% | 49 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| John James |
Sep 2, 24 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
May 6, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
Read more about Sanofi (SNY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Sanofi?
The Market Cap of Sanofi is $128B.
What is Sanofi's PE Ratio?
As of today, Sanofi's PE (Price to Earnings) ratio is 18.38.
What is the current stock price of Sanofi?
Currently, the price of one share of Sanofi stock is $52.08.
How can I analyze the SNY stock price chart for investment decisions?
The SNY stock price chart above provides a comprehensive visual representation of Sanofi's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Sanofi shares. Our platform offers an up-to-date SNY stock price chart, along with technical data analysis and alternative data insights.
Does SNY offer dividends to its shareholders?
Yes, Sanofi (SNY) offers dividends to its shareholders, with a dividend yield of 4.26%. This dividend yield represents Sanofi's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Sanofi in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Sanofi?
Some of the similar stocks of Sanofi are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.